Neurones SA
PAR:NRO

Watchlist Manager
Neurones SA Logo
Neurones SA
PAR:NRO
Watchlist
Price: 44.35 EUR 1.72% Market Closed
Market Cap: 1.1B EUR
Have any thoughts about
Neurones SA?
Write Note

Intrinsic Value

The intrinsic value of one NRO stock under the Base Case scenario is 44 EUR. Compared to the current market price of 44.35 EUR, Neurones SA is Overvalued by 1%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

NRO Intrinsic Value
44 EUR
Overvaluation 1%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Neurones SA

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
NRO
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for NRO cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about NRO?
Bearish
Neutral
Bullish

Fundamental Analysis

44.35 EUR
+1.72%
+1.72%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Neurones SA
FR
Technology
Market Cap
1.1B EUR
IPO
May 23, 2000
Employees
5 663
France
Market Cap
1.1B EUR
Industry
Technology
IPO
May 23, 2000
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Neurones SA

Provide an overview of the primary business activities
of Neurones SA.

What unique competitive advantages
does Neurones SA hold over its rivals?

What risks and challenges
does Neurones SA face in the near future?

Has there been any significant insider trading activity
in Neurones SA recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Neurones SA.

Provide P/S
for Neurones SA.

Provide P/E
for Neurones SA.

Provide P/OCF
for Neurones SA.

Provide P/FCFE
for Neurones SA.

Provide P/B
for Neurones SA.

Provide EV/S
for Neurones SA.

Provide EV/GP
for Neurones SA.

Provide EV/EBITDA
for Neurones SA.

Provide EV/EBIT
for Neurones SA.

Provide EV/OCF
for Neurones SA.

Provide EV/FCFF
for Neurones SA.

Provide EV/IC
for Neurones SA.

Show me price targets
for Neurones SA made by professional analysts.

What are the Revenue projections
for Neurones SA?

How accurate were the past Revenue estimates
for Neurones SA?

What are the Net Income projections
for Neurones SA?

How accurate were the past Net Income estimates
for Neurones SA?

What are the EPS projections
for Neurones SA?

How accurate were the past EPS estimates
for Neurones SA?

What are the EBIT projections
for Neurones SA?

How accurate were the past EBIT estimates
for Neurones SA?

Compare the revenue forecasts
for Neurones SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Neurones SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Neurones SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Neurones SA compared to its peers.

Compare the P/E ratios
of Neurones SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Neurones SA with its peers.

Analyze the financial leverage
of Neurones SA compared to its main competitors.

Show all profitability ratios
for Neurones SA.

Provide ROE
for Neurones SA.

Provide ROA
for Neurones SA.

Provide ROIC
for Neurones SA.

Provide ROCE
for Neurones SA.

Provide Gross Margin
for Neurones SA.

Provide Operating Margin
for Neurones SA.

Provide Net Margin
for Neurones SA.

Provide FCF Margin
for Neurones SA.

Show all solvency ratios
for Neurones SA.

Provide D/E Ratio
for Neurones SA.

Provide D/A Ratio
for Neurones SA.

Provide Interest Coverage Ratio
for Neurones SA.

Provide Altman Z-Score Ratio
for Neurones SA.

Provide Quick Ratio
for Neurones SA.

Provide Current Ratio
for Neurones SA.

Provide Cash Ratio
for Neurones SA.

What is the historical Revenue growth
over the last 5 years for Neurones SA?

What is the historical Net Income growth
over the last 5 years for Neurones SA?

What is the current Free Cash Flow
of Neurones SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Neurones SA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Neurones SA

Current Assets 546.3m
Cash & Short-Term Investments 264.2m
Receivables 267m
Other Current Assets 15.1m
Non-Current Assets 133.1m
Long-Term Investments 10.9m
PP&E 60.2m
Intangibles 55.6m
Other Non-Current Assets 6.4m
Current Liabilities 243.4m
Accounts Payable 52.2m
Accrued Liabilities 126.3m
Short-Term Debt 4.9m
Other Current Liabilities 60m
Non-Current Liabilities 86.3m
Long-Term Debt 30.1m
Other Non-Current Liabilities 56.1m
Efficiency

Earnings Waterfall
Neurones SA

Revenue
774.9m EUR
Cost of Revenue
-722k EUR
Gross Profit
774.2m EUR
Operating Expenses
-700.6m EUR
Operating Income
73.6m EUR
Other Expenses
-25.1m EUR
Net Income
48.5m EUR

Free Cash Flow Analysis
Neurones SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

NRO Profitability Score
Profitability Due Diligence

Neurones SA's profitability score is 60/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Year Average ROIC
Positive Free Cash Flow
Positive 3-Years Revenue Growth
60/100
Profitability
Score

Neurones SA's profitability score is 60/100. The higher the profitability score, the more profitable the company is.

NRO Solvency Score
Solvency Due Diligence

Neurones SA's solvency score is 74/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
High Altman Z-Score
Short-Term Solvency
74/100
Solvency
Score

Neurones SA's solvency score is 74/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NRO Price Targets Summary
Neurones SA

There are no price targets for NRO.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for NRO?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for NRO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

NRO Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

See Also

Discover More
What is the Intrinsic Value of one NRO stock?

The intrinsic value of one NRO stock under the Base Case scenario is 44 EUR.

Is NRO stock undervalued or overvalued?

Compared to the current market price of 44.35 EUR, Neurones SA is Overvalued by 1%.

Back to Top